Language selection

Search

2009-12-04 - Male - 11 Years old

334399

Adverse reaction report number 334399
Latest AER version number 2
Market authorization holder AER number SPV1200902396
Initial received date 2009-12-04
Latest received date 2010-02-24
Age 11 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Recovered/resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral5 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Depressed mood3 Month(s)
Depression3 Month(s)
Suicidal ideation3 Month(s)
Date modified: